NRX Pharmaceuticals
Manufacturing · Delaware, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
1201 N Orange St Ste 600, Wilmington, De...Phone Number
(484) 254-6134Website
www.nrxpharma.comRevenue
<$5 MillionStock Symbol
NRXPIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About NRX Pharmaceuticals
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel treatments for central nervous system disorders, including life-threatening forms of depression and post-traumatic stress disorder. It uses a scientific platform targeting the brains NMDA receptor to advance drug candidates such as preservative-free ketamine formulations and oral therapies designed to address unmet needs in severe mental health conditions. The company also supports healthcare delivery through its interventional psychiatry clinic network.Explore more
NRX Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NRX Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
NRX Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at NRX Pharmaceuticals
Check out if NRX Pharmaceuticals is spiking on competitors!
Funding: Get notified immidiatlly once NRX Pharmaceuticals has new funding data
Product Launch: Get notified when NRX Pharmaceuticals launches new products
Website visits: Recent activity has been detected on your website
Check if NRX Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Click to see if NRX Pharmaceuticals had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on NRX Pharmaceuticals recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined NRX Pharmaceuticals as Masked Content
Find 2 more new buyers
Compare Similar Companies to NRX Pharmaceuticals
Compare insights from companies similar to NRX Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
NRX Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
NRX Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about NRX Pharmaceuticals.
NRX Pharmaceuticals financials insights
Gather financial insights about NRX Pharmaceuticals, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2022
Share Placement
$25M
Debt
$11M
2024
Share Placement
$5M
Debt
$16M
2025
Other Financing Round
$8.9M
NRX Pharmaceuticals Tech Stack
A closer look at the technologies used by NRX Pharmaceuticals
See more technologies
Most Recent Scoops
New Hire
Executive Move
Glenn Tyson has recently joined the organization as Chief Commercial Officer.
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Project
NRX Pharmaceuticals has noted that the upcoming trial involves only a day or a couple of days of D-cycloserine treatment rather than six weeks, reducing the risk that patients might not be compliant with the study drug to near zero.
Pharmaceuticals, Clinical Operations, Patient Experience
Project
Pharmaceuticals, Artificial Intelligence, Healthcare Technology
NRX Pharmaceuticals News & Media
FDA Completes First-Cycle Review of Preservative-Free Ketamine ANDA with No Drug Related Major Deficiencies; Final Packaging Certification Requested for Approval
MIAMI, Aug. 07, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) today announced that the FDA has completed first-cycle review of the Company’s ANDA for its preservative-free ketamine, with no major deficiencies related to the drug product, ingredients, proposed labeling, Chemistry, Manufacturing and Controls, or other drug-related review matters. No new clinical, safety, efficacy, or drug-related data are required for ANDA approval. Following receipt of the FDA comments, the CoNRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute
WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) (“NRx” or the “Company”) today issued the following statement in response to recent public claims made by Kadima Neuropsychiatry Institute (“Kadima”).NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System
WILMINGTON, Del., June 25, 2026 (GLOBE NEWSWIRE) -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", "NRx" or the "Company"), a clinical-stage biopharmaceutical company, today announced that its subsidiary, HOPE Therapeutics, Inc. ("HOPE"), has treated its first patients using Zeta Surgical's FDA-cleared Zeta TMS Navigation System. HOPE has installed Zeta TMS Navigation Systems at its clinics in West Palm Beach and Sarasota, Florida, with Zeta-navigated patient treatments now undZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics
SARASOTA, Fla, and BOSTON, June 23, 2026 /PRNewswire/ -- ZETA SURGICAL and HOPE Therapeutics, an NRx Pharmaceuticals company (Nasdaq: NRXP), today announced the first patient treatment with the FDA-cleared Zeta TMS Navigation System at a HOPE Therapeutics clinic in Sarasota. HOPE has...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding NRX Pharmaceuticals
Sign Up For FreeTo access detailed company insights
NRx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel treatments for central nervous system disorders, including life-threatening forms of depression and post-traumatic stress disorder. It uses a scientific platform targeting the brains NMDA receptor to advance drug candidates such as pr... Read More
